Journal: Frontiers in Pharmacology
Article Title: Rus-GXF, a ruscogenin glycoside, binds to the ADP-binding domain of JAK1 to prevent inflammation and barrier damage in acute lung injury
doi: 10.3389/fphar.2026.1730503
Figure Lengend Snippet: Anti-inflammatory effect of monomeric Rus-GXF on LPS-induced RAW264.7 cells. (A) CCK-8 assay of Rus-GXF on RAW264.7 cells ( n = 6). (B–D) Cell culture supernatant NO, IL-6 and TNF-α content assay ( n = 4). (E,F) Real-time fluorescence quantitative PCR assay to detect the relative gene expression of COX2 and iNOS ( n = 4). Bars are expressed as mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001.
Article Snippet: After 6 h, cells were treated with serially diluted Rus-GXF (RAW264.7: 0, 1, 10, 20, 40, 60 μM; BEAS-2B: 0, 1, 10, 20, 40, 80, 160 μM; n = 3) for 24 h. Then, 110 μL of CCK-8 working solution (CCK-8/complete medium = 1/10; Beijing Solarbio Science & Technology Co., Ltd.) was added per well.
Techniques: CCK-8 Assay, Cell Culture, Fluorescence, Real-time Polymerase Chain Reaction, Gene Expression